Cancer clinical trials in the region Bourgogne-Franche-Comté
210 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 3
Prostate cancer
#NCT06136650
Adenocarcinoma
Metastatic Castration-resistant
Hormone therapy
Hormone therapy
Systemic Treatment-Naive
Internal Vectorised Radiotherapy (IVR)
Systemic Treatment-Naive
Internal Vectorised Radiotherapy (IVR)
Clinique La Croix du Sud - Ramsay Santé (Quint-Fonsegrives), Centre Hospitalier Universitaire de Bordeaux (Bordeaux), Centre Jean Perrin (Clermont Ferrand ), Hôpital Foch (Suresnes), Institut Sainte Catherine (Avignon) (and 4 more...)
Merck Sharp & Dohme LLC
Phase 3
Lymphoma
#NCT04224493
B cell lymphoma
Follicular lymphoma
None
> 60 ml/min
50-60 ml/min
30-50 ml/min
Chemotherapy
Targeted therapy
Radiotherapy
1
2
3 or more
Systemic Treatment-Naive
Gustave Roussy (Villejuif), Centre Hospitalier Universitaire Angers (Angers ), Centre Hospitalier de Périgueux (Périgueux), Centre Hospitalier de Lens (Lens), Hôpital Claude Huriez (Lille) (and 16 more...)
Epizyme, Inc. (Ipsen)
Phase 3
Breast cancer
#NCT06065748
HER2 Negative
HR Positive
Locally Advanced
Metastatic
ESR
Hormone therapy
Systemic Treatment-Naive
Systemic Treatment-Naive
Centre François Baclesse (Caen ), Centre Eugene Marquis (Rennes), Centre Oscar Lambret (Lille), Gustave Roussy (Villejuif), Centre Léon Bérard (Lyon) (and 6 more...)
Hoffmann-La Roche
Phase 3
Breast cancer
#NCT05654623
HER2 Negative
HR Positive
Locally Advanced
Metastatic
Hormone therapy
Targeted therapy
Chemotherapy
Systemic Treatment-Naive
Centre Jean Perrin (Clermont Ferrand ), Hôpital Henri-Mondor AP-HP (Créteil), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain), Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ) (and 1 more...)
Pfizer
Phase 3
Breast cancer
#NCT05629585
HER2 Negative
HR Negative
Locally Advanced
Localized
Chemotherapy
Surgery
Chemotherapy
Surgery
BRCA 1/2
Institut Bergonié (Bordeaux), Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Hôpital Privé Jean Mermoz - Ramsay Santé (Lyon), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Centre Hospitalier Annecy Genevois (Epagny Metz-Tessy) (and 8 more...)
AstraZeneca
Phase 3
Anal cancer
#NCT06207981
Locally Advanced
Radiotherapy
Radiotherapy
CHU - Haut-lévêque - Bordeaux (Pessac), Hôpital Privé Jean Mermoz - Ramsay Santé (Lyon), Hôpital privé d'Antony - Ramsay Santé (Antony)
Fédération Francophone de Cancérologie Digestive
Phase 3
Lung cancer
#NCT05153239
SCLC (Small Cell Lung Cancer)
Metastatic
Chemotherapy
Chemotherapy
Centre François Baclesse (Caen ), Hôpital Ambroise-Paré AP-HP (Boulogne-Billancourt), Hôpital Foch (Suresnes), Centre Hospitalier Universitaire de Besançon (Besançon), CHU Caen Normandie (Caen) (and 8 more...)
PharmaMar
Phase 3
Breast cancer
#NCT05038735
HER2 Negative
HR Positive
Locally Advanced
Metastatic
PIK3CA
Hormone therapy
Targeted therapy
Hormone therapy
Targeted therapy
Systemic Treatment-Naive
Hôpital Privé Clairval - Ramsay Santé (Marseille), Centre Hospitalier Universitaire de Besançon (Besançon), Centre Jean Perrin (Clermont Ferrand ), Centre Léon Bérard (Lyon), Hôpital Saint Louis AP-HP (Paris) (and 5 more...)
Novartis
Phase 3
Lung cancer
#NCT04928846
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
Metastatic
MET
Chemotherapy
Immunotherapy
Targeted therapy
EGFR
Systemic Treatment-Naive
Antibody Drug Conjugates (ADC)
Institut Curie - Paris (Paris), Hôpital Nord de Marseille (Marseille Cedex 20), Centre Hospitalier Intercommunal Créteil (Créteil Cedex), CHU - Haut-lévêque - Bordeaux (Pessac), Centre Hospitalier Universitaire de Montpellier - Site Arnaud de Villeneuve (Montpellier) (and 4 more...)
Abbvie
Phase 3
Breast cancer
#NCT04873362
HER2 Positive
Locally Advanced
Localized
Chemotherapy
Targeted therapy
Chemotherapy
Targeted therapy
Immunotherapy
Immunotherapy
Groupe Hospitalier Diaconesses - Site Croix Saint Simon (Paris), Centre Léon Bérard (Lyon), Groupe Hospitalier Public du Sud de l'Oise (Creil), Centre Hospitalier Universitaire de Besançon (Besançon), Institut Sainte Catherine (Avignon) (and 3 more...)
Hoffmann-La Roche